A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma
Latest Information Update: 02 May 2024
At a glance
- Drugs Levocetirizine (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Acronyms HAS3
- 25 Apr 2024 Planned End Date changed from 1 Oct 2025 to 1 May 2025.
- 25 Apr 2024 Planned primary completion date changed from 1 Oct 2025 to 1 May 2025.
- 22 Apr 2022 Planned End Date changed from 1 Jan 2026 to 1 Oct 2025.